Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze RLAY stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate RLAY investment potential.

What is RLAY stock price today?

Get real-time RLAY stock price, historical data, and price charts on Financhill. Track RLAY performance with our advanced analysis tools.

Is RLAY a good investment?

Evaluate RLAY investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy RLAY stock?

To buy RLAY stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of RLAY?

View detailed market capitalization data and company valuation metrics for RLAY on our comprehensive analysis page.

What is the P/E ratio of RLAY?

Use our fundamental analysis tools to view RLAY P/E ratio and compare valuation metrics with industry peers.

What are RLAY earnings?

View RLAY earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Relay Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

RLAY
Relay Therapeutics, Inc.

Last Price:

$10.16

Seasonality Move:

-27.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Relay Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Relay Therapeutics, Inc. has on average historically fallen by 5.8% based on the past 5 years of stock performance.
Relay Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Is Relay Therapeutics, Inc. Stock Undervalued?

The current Relay Therapeutics, Inc. [RLAY] share price is $10.15. The Score for RLAY is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
RLAY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Relay Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Relay Therapeutics, Inc. has on average historically fallen by 5.8% based on the past 5 years of stock performance.

Relay Therapeutics, Inc. Stock Rating

Buy

Relay Therapeutics, Inc. (RLAY) is a Buy

Is Relay Therapeutics, Inc. overpriced?

Relay Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Relay Therapeutics, Inc. Stock Price History

Is RLAY stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RLAY is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

relaytx.com

52-Week Data

52-Week High:

11.43

52-Week Low:

1.78

Prediction Charts

Market Cap:

1.8B

Price in USD:

10.15

Volume:

2.7M

Beta:

1.65

Technical Analysis

SMA50:

8.47

SMA100:

7.79

SMA200:

5.76

52-Wk Change:

218.18%

Stock Predictions

Is Relay Therapeutics, Inc. stock public?

Yes, Relay Therapeutics, Inc. is a publicly traded company.
What is the Relay Therapeutics, Inc. stock quote today?

The Relay Therapeutics, Inc. stock price is 10.15 USD today.
How to buy Relay Therapeutics, Inc. stock online?

You can buy Relay Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Feb-12	9.14	8.81	9.32	8.35
Feb-13	8.85	8.93	9.54	8.85
Feb-17	8.88	9.16	9.43	8.81
Feb-18	9.02	9.10	9.32	8.97
Feb-19	8.97	8.86	9.00	8.69
Feb-20	8.79	8.70	8.90	8.42
Feb-23	8.66	8.94	9.01	8.65
Feb-24	8.99	9.18	9.50	8.99
Feb-25	9.25	9.22	9.49	9.13
Feb-26	9.19	9.16	9.41	8.84
Feb-27	9.64	10.26	11.43	9.40
Mar-2	9.91	9.79	10.68	9.76
Mar-3	9.56	9.85	10.50	9.28
Mar-4	9.93	10.15	10.25	9.55

Relay Therapeutics, Inc. Earnings

Relay Therapeutics, Inc. Earnings Report: Per Share Relay Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Relay Therapeutics, Inc. Forecast Revenue Growth

Relay Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Relay Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.03 per share, an increase this year of $0.17 per share, and an increase next year of $0.02 per share.

* Relay Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.